The MLH1 gene helps repair small copying mistakes that happen when cells divide. This gene plays an important role in keeping DNA stable, and if it does not work properly, errors can build up and raise the chance of certain cancers, especially colon and endometrial cancer. A harmful variant in one copy of the MLH1 gene is a known cause of Lynch syndrome, an inherited cancer condition. Much less often, variants in both copies can cause a childhood condition called constitutional mismatch repair deficiency.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes hold the instructions for producing proteins, the parts of cells that do the work. Other genes mainly regulate when certain processes happen, where they happen, and how strongly they run. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
MLH1Gene function
What if the gene works
The MLH1 gene helps cells fix small DNA copying mistakes. This supports stable genetic information and more controlled cell growth.
Risk
What if the gene does not work
Variants in the MLH1 gene can weaken DNA repair and raise the chance of Lynch syndrome cancers, especially bowel and uterine cancers. Milder or more severe variants may affect timing and features; two nonworking copies can lead to childhood cancer risk.
Treatment
What does that mean for your treatment
Pathogenic variants in the MLH1 gene can affect cancer treatment because tumors with MLH1 loss often have mismatch repair deficiency (trouble fixing DNA copying mistakes) and may respond to immune checkpoint inhibitors such as pembrolizumab, dostarlimab, or nivolumab in guideline-based settings. In colon cancer, this pattern can also mean less benefit from fluorouracil-only treatment after surgery in some early-stage cases.
Conditions associated with MLH1
Gene function
What if the gene works
Each time a cell divides, it has to copy a huge amount of DNA with very few errors. The MLH1 gene helps manage that quality check by supporting the repair of small copying mistakes. This steady repair work is a key part of how the body keeps genetic information accurate over time.
The MLH1 gene helps your cells spot tiny DNA copying mistakes that can happen during cell division. These are small letter swaps or short extra or missing pieces left behind after DNA is copied.
Inside your cells, the MLH1 gene works through its protein with partner proteins to organize repair. It helps mark the problem area so the incorrect stretch can be removed and replaced with the right DNA sequence.
By fixing routine copy slips, the MLH1 gene helps keep your genetic information stable from one cell generation to the next. This is part of how the MLH1 gene helps repair DNA mistakes during cell division and supports normal tissue renewal.
What is a variant?
A genetic variant is a small change in the DNA sequence of a gene. These changes are common and help account for normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, however, a variant can change the function of a gene more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In understanding how variants influence the MLH1 gene's function, the key point is that some changes shorten the protein, make it unstable, or stop it from pairing with PMS2, so DNA copying mistakes remain. Milder variants may leave some repair activity, while more severe variants can greatly reduce or abolish it. In people with Lynch syndrome, stronger loss of MLH1 function often relates to a clearer inherited cancer pattern and, in some families, earlier disease.
How variants are linked to conditions
Pathogenic variants in the MLH1 gene cause Lynch syndrome, an inherited condition linked to a higher lifetime risk of colorectal and endometrial cancer, as well as some ovarian, stomach, urinary tract, and other cancers. This is the main way MLH1 gene variants are linked to conditions. When a person inherits disease-causing variants in both copies of the MLH1 gene, it can lead to constitutional mismatch repair deficiency, a rare cancer predisposition condition that often begins in childhood.
A variant is not necessarily a diagnosis
Variants in DNA are a routine part of being human and are widely seen across the population. Most do not directly affect health and instead reflect normal human variation. For many genes, having a variant associated with a condition points to a possible link, not a clear diagnosis, particularly when several genes and environmental influences also play a role. In certain situations, though, one well-characterized variant in a particular gene is enough to establish a diagnosis.
Are there things that can increase or change my risk?
For people with a harmful MLH1 variant, much of the cancer risk is already set by the inherited change, and risk also varies with age, sex, and family history. Smoking may further raise the chance of some cancers, while regular screening helps catch problems early rather than changing the inherited risk itself.
Inheritance of MLH1 variants
How variants of the MLH1 gene are inherited depends on the condition involved. For Lynch syndrome, MLH1-related variants usually follow an autosomal dominant pattern, which means a parent with the variant can pass it to a child of any sex with a 50% chance. A rarer childhood condition linked to the MLH1 gene, called constitutional mismatch repair deficiency, follows an autosomal recessive pattern and happens when a child inherits one pathogenic variant from each parent. In that setting, two carrier parents have a 25% chance with each pregnancy of having an affected child.
What does my MLH1 result mean for my family?
For many living with an MLH1 gene change linked to Lynch syndrome, close relatives such as parents, brothers, sisters, and children may also carry the same change, so the result can matter across the family. MLH1 can also be tied to a much rarer condition in children when both copies are changed, so the family meaning depends on the exact result and condition involved. In some families, relatives may be carriers even if they have never had cancer.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the MLH1 gene usually uses a blood or saliva sample. A lab reads the DNA in the MLH1 gene and looks for changes that are known to be disease-causing, harmless, or uncertain. In some families, this can confirm Lynch syndrome.
When should I consider getting a genetic test?
Consider genetic testing for changes in the MLH1 gene if you or close relatives have had colon cancer, cancer of the womb (uterus), or several related cancers, especially at a younger age. It can also help when testing on a cancer sample suggests Lynch syndrome, an inherited condition that raises the chance of certain cancers.
A genetic result is only one part of your health story
How much a genetic result can tell you depends on the condition and the kind of variant involved, even though it can provide valuable insight. Age, lifestyle, environment, and medical history, among other factors, also influence how the body works over time. For some conditions, especially ones shaped by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences in perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This is common and helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can shape their response to medicines. It focuses on the relationship between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medications, genes can affect how strongly a drug works or how the body handles it. Understanding this can support more informed and individualized treatment decisions. More information on this topic is available in the LearnHub.
Drugs influenced by the MLH1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in routine medication response, so general questions about medicines, side effects, or treatment changes are best discussed with your doctor. In cancer care, changes involving MLH1 in a tumor can help guide some treatment choices, especially certain immune-based treatments, so this is worth discussing with your oncology team.
History
The MLH1 gene became historically important when scientists worked to explain why some families developed colon and other cancers across generations. In the early 1990s, studies of hereditary nonpolyposis colorectal cancer, now more often called Lynch syndrome, led researchers to the MLH1 gene as one of the key inherited causes. Building on this early work, scientists uncovered more about the gene and connected it to the body’s system for correcting DNA copying errors. That discovery helped reshape cancer genetics by showing that some inherited cancer risk comes from faults in this repair pathway. As testing improved, the MLH1 gene became part of routine evaluation for families with Lynch syndrome and helped guide screening and prevention discussions.